Elena Campaner

Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment

C. Tripodo, G. Del Sal, F. Zanconati, 2020, Cancers.

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

N. Alon, S. Bicciato, A. Rosato, 2020, Nature Communications.

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

A. Rosato, P. Carloni, E. Baloglu, 2017, Nature Communications.

Oncogenic Hijacking of the PIN1 Signaling Network

G. Del Sal, A. Rustighi, Alessandro Zannini, 2019, Front. Oncol..

The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress.

S. Gustincich, E. Maspero, C. Tripodo, 2021, Cell reports.

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells

D. Walerych, G. Del Sal, Y. Ciani, 2018, Oncotarget.

PIN1 in breast development and cancer: a clinical perspective

G. Sal, S. Piazza, A. Rustighi, 2016, Cell Death and Differentiation.